Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes

British Journal of Pharmacology

Volumn 127, Issue 7, 1999, Pages 1641-1651

  Cortijo, J ^a   Villagrasa, V ^a   Pons, R ^a   Berto, L ^a   Marti Cabrera M ^a   Martinez Losa, M ^a   Domenech, T ^b   Beleta, J ^b   Morcillo, E J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Centro de Investigación y Desarrollo   (Spain)

Author keywords

Glaucine; Human airway smooth muscle; Human eosinophils; Human polymorphonuclear leukocytes

Indexed keywords

BRONCHODILATING AGENT; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLAUCINE; HISTAMINE; ISOPRENALINE; LEUKOTRIENE B4; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN MEMBRANE; BRONCHODILATING ACTIVITY; BRONCHUS MUSCLE; DRUG BINDING; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APORPHINES; BRONCHI; BRONCHODILATOR AGENTS; CALCIUM; CELLS, CULTURED; CYCLIC AMP; EOSINOPHILS; HUMANS; LEUKOTRIENE B4; MUSCLE RELAXATION; MUSCLE, SMOOTH; NEUTROPHILS; PANCREATIC ELASTASE; PHOSPHODIESTERASE INHIBITORS; PLATELET AGGREGATION; SUPEROXIDES;

EID: 0032775316     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702702     Document Type: Article

References (48)

1. ADVENIER, C., NALINE, E. & RENIER, A. (1986). Effect of Bay K 8644 on contraction of human isolated bronchus and guinea-pig isolated trachea. Br. J. Pharmacol., 88, 33-39.
2. BARNES, P.J. (1985). Clinical studies with calcium antagonists in asthma. Br. J. Clin. Pharmacol., 20, 289S-298S.
3. BARNES, P.J., IND, P. & DOLLERY, C.T. (1981). Inhaled prazosin in asthma. Thorax, 36, 378-381.
4. BARNETTE, M.S., CHRISTENSEN, S.B., ESSAYAN, D.M., GROUS, M., PRABHAKAR, U., RUSH, J.A., KAGEY-SOBOTKA, A. & TORPHY, T.J. (1998). SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. J. Pharmacol. Exp. Ther., 284, 420-426.
5. BEAVO, J.A., CONTI, M. & HEASLIP, R.J. (1994). Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol., 46, 399-405.
6. BLACK, J.L. & ARMOUR, C.L. (1986). χ-Adrenoceptor function in asthma. Trends Pharmacol. Sci., 7, 303-304.
7. BÖYUM, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 21 (suppl. 97): 77-89.
8. CHIJIWA, T., MISHIMA, A., HAGIWARA, M., SANO, M., HAYASHI, K., INOUE, T., NAITO, K., TOSSHIOKA, T. & HIDAKA, T. (1990). Inhibition of forskolin-induced outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC 12D Pheochromocytoma cells. J. Biol. Chem., 265, 5267-5272.
9. COHEN, V.L., SHOWELL, H.J., FISHER, D.A., PAZOLES, C.J., WATSON, J.W., TURNER, C.R. & CHENG, J.B. (1996). In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. J. Pharmacol. Exp. Ther., 278, 1356-1361.
10. COLLADO, M.C., BELETA, J., MARTINEZ, E., MIRALPEIX, M., DOMENECH, T., PALACIOS, J.M. & HERNANDEZ, J. (1998). Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor. Br. J. Pharmacol., 123, 1047-1054.
11. CONSTANT, O., SLAVIN, B., LEHANE, J.R., JORDAN, C. & JONES, J.G. (1983). Effect of the antitussive glaucine on bronchomotor tone in man. Thorax, 38, 537-542.
12. CORTIJO, J., BOU, J., BELETA, J., CARDELÚS, I., LLENAS, J., MORCILLO, E. & GRISTWOOD, R.W. (1993). Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br. J. Pharmacol., 108, 562-568.
13. CORTIJO, J., VILLAGRASA, V., MARTÍ-CABRERA, M., VILLAR, V., MOREAU, J., ADVENIER, C., MORCILLO, E.J. & SMALL, R.C. (1997). The spasmogenic effects of vanadate in human isolated bronchus. Br. J. Pharmacol., 121, 1339-1349.
14. CORTIJO, J., VILLAGRASA, V., NAVARRETE, C., SANZ, C., BERTO, L., MICHEL, A., BONNET, P.A. & MORCILLO, E.J. (1996). Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and leveromakalim. Br. J. Pharmacol., 119, 99-106.
15. DE VRIES, G.W., AMDAHL, L.D., KRAMER, K.D. & WHEELER, L.A. (1990). Inhibition by manoalide of fMLP-stimulated elastase release from human neutrophils. Biochem. Pharmacol., 40, 2487-2494.
16. DIERCKX, P., LEBLANC, G., DECOSTER, A. & CRISCUOLO, D. (1981). Double blind study of glaucine in chronic cough. Int. J. Clin. Pharmacol., 19, 396-399.
17. ECKLY-MICHEL, A., MARTIN, V. & LUGNIER, C. (1997). Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br. J. Pharmacol., 122, 158-164.
18. FUJII, K., KOHROGI, H., IWAGOE, H., HAMAMOTO, J., HIRATA, N., GOTO, E., KAWANO, O., WADA, K., YAMAGATA, S. & ANDO, M. (1998). Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen. J. Pharmacol. Exp. Ther., 284, 162-169.
19. GILLISSEN, A., JAWORSKA, M., SCHÄRLING, B., VAN ZWOLL, D. & SCHULTZE-WERNINGHAUS, G. (1997). Beta-2-Agonists have antioxidant function in vitro. Respiration, 64, 16-22.
20. GRISTWOOD, R.W., BELETA, J., BOU, J., CARDELUS, I., FERNANDEZ, A.G., LLENAS, J. & BERGA, P. (1992). Studies on the cardiac actions of flosequinan in vitro. Br. J. Pharmacol., 105, 985-991.
21. HALL, I.P., WIDDOP, S., TOWNSEND, P. & DAYKIN, K. (1992). Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells. Br. J. Pharmacol., 107, 422-428.
22. HANSEL, T.T., DE VRIES, J.M., IFF, T., RIHS, S., WANDZILAK, M., BETZ, S., BLASER, K. & WALKER, C. (1991). An improved immunomagnetic procedure for the isolation of highly purified human blood cosinophils. J. Immunol. Meth., 145, 105-110.
23. HATZELMANN, A., HAURAND, M. & ULLRICH, V. (1990). Involvement of calicum in the thimerosal-stimulated formation of leukotriene by fMLP in human polymorphonuclear leukocytes. Biochem. Pharmacol., 39, 559-567.
24. HATZELMANN, A., TENOR, H. & SCHUDT, C. (1995). Differential effects of non-selective phosphodiesterase inhibitors on human eosinophil functions. Br. J. Pharmacol., 14, 821-831.
25. 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Br. J. Pharmacol., 106, 387-394.
26. KASÉ, Y., KAWAGUCHI, M., TAKAHAMA, K., MIYATA, T., HIROTSU, J., HITOSHI, T. & OKANO, Y. (1983). Pharmacological studies on dl-glaucine phosphate as an antitussive. Arzneim. Forsch., 33, 936-946.
27. KUKOVETZ, W.R. & PÖCH, G. (1970). Inhibition of cyclic-3′,5′-nucleotide phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn-Schmiedeberg's Arch. Pharmacol., 267, 189-194.
28. + channel opening by stimulation of adenylate cyclase in rat isolated aorta. Br. J. Pharmacol., 115, 515-521.
29. LOWRY, O.H., ROSENBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
30. 4-. J. Pharmacol. Exp. Ther., 268, 139-143.
31. MURRAY, R.K. & KOTLIKOFF, M.I. (1991). Receptor-activated calcium influx in human airway smooth muscle cells. J. Physiol., 435, 123-144.
32. MUSGRAVE, I.F. & SEIFERT, R. (1994). Human neutrophils and HL-60 cells do not possess alpha 2-adrenoceptors. Biochem. Pharmacol., 41, 233-239.
33. NALINE, F., QIAN, Y., ADVENIER, C., RAEBURN, D. & KARLSSON, J.A. (1996). Effects of RP 73401, a novel, potent and selective phosphodiesterase type 4 inhibitor, on contractility of human, isolated bronchial muscle. Br. J. Pharmacol., 118, 1939-1944.
34. ORALLO, F., ALZUETA, A.F., LOZA, M.I., VIVAS, N., BADIA, A., CAMPOS, M., HONRUBIA, M.A. & CADAVID, M.I. (1993). Study of the mechanism of the relaxant action of (+)-glaucine in rat vas deferens. Br. J. Pharmacol., 110, 943-948.
35. QIAN, Y., NALINE, E., KARLSSON, J.A., RAEBURN, D. & ADVENIER, C. (1993). Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside. Br. J. Pharmacol., 109, 774-778.
36. RENESTO, P., BALLOY, V., VARGAFTIG, B.B. & CHIGNARD, M. (1991). Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine. Br. J. Pharmacol., 103, 1435-1440.
37. 2+ release from intracellular stores in neutrophils. J. Biol. Chem., 267, 1443-1448.
38. i. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 682-690.
39. SEDGWICK, J.B., VRTIS, R.F., GOURLEY, M.F. & BUSSE, W.W. (1988). Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J. Allergy Clin. Immunol., 81, 876-883.
40. SOUNESS, J.E., MASLEN, C., WEBBER, S., FOSTER, M., RAEBURN, D., PALFREYMAN, M.N., ASHTON, M.J. & KARLSSON, J.A. (1995). Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Br. J. Pharmacol., 115, 39-46.
41. SULLIVAN, P., BEKIR, S., JAFFAR, Z., PAGE, C., JEFFREY, P. & COSTELLO, J. (1994). Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet, 343, 1006-1008. (Erratum: Lancet, 1994; 343, 1512).
42. SYNEK, M., BEASLEY, R., FREW, A.J., GOULDING, D., HOLLOWAY, L., LAMPE, F.C., ROCHE, W.R. & HOLGATE, S.T. (1996). Cellular infiltration of the airways in asthma of varying severity. Am. J. Respir. Crit. Care Med., 154, 224-230.
43. THOMPSON, W.J. & STRADA, S.J. (1984). Cyclic nucleotide phosphodiesterase (PDE). In Methods of Enzymatic Analysis. ed. Bergmayer III, H.U., Vol. IV, pp. 127-134. Weinheim: Verlag Chemie.
44. TORPHY, T.J. (1994). β-Adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol. Sci., 15, 370-374.
45. TORPHY, T.J. (1998). Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents (State of the art). Am. J. Respir. Crit. Care Med., 157, 351-370.
46. VAN INWEGEN, R.G., SALAMAN, P., ST. GEORGIER, V. & WEINRYB, I. (1979). Dihydro and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Biochem. Pharmacol., 28, 1307-1312.
47. VAN ROSSUM, J.M. (1963). Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther., 143, 299-330.
48. WATSON, N., MAGNUSSEN, H. & RABE, K.F. (1998). The relevance of resting tension to responsiveness and inherent tone of human bronchial smooth muscle. Br. J. Pharmacol., 123, 694-700.